Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134739) titled 'Comparison of Tergicidine Fumarate and Sufentanil on Quality of Recovery After Laparoscopic Radical Hysterectomy: A Multicenter Randomized Controlled Trial' on Oct. 20.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: General Hospital of the Northern Theater Command of the People's Liberation Army of China
Condition:
Pain after laparoscopic radical hysterectomy
Intervention:
Tegileridine group:Thirty minutes before the anticipated end of surgery, 0.75 mg of tergicidine fumarate was administered intravenously, diluted to a total volume of 10 mL with 0.9% sodium chloride solution, and ...